Envestnet Asset Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,796
Closed -$197K 4741
2025
Q4
$197K Sell
12,796
-8,092
-39% -$89.1K ﹤0.01% 4275
2025
Q3
$207K Buy
20,888
+7,441
+55% +$77.4K ﹤0.01% 4301
2025
Q2
$133K Sell
13,447
-564
-4% -$5.94K ﹤0.01% 4301
2025
Q1
$182K Sell
14,011
-2,151
-13% -$28.5K ﹤0.01% 4161
2024
Q4
$206K Buy
16,162
+2,796
+21% +$33.8K ﹤0.01% 4084
2024
Q3
$149K Sell
13,366
-1,692
-11% -$18.7K ﹤0.01% 4068
2024
Q2
$169K Buy
15,058
+3,595
+31% +$41.8K ﹤0.01% 3972
2024
Q1
$142K Buy
+11,463
New +$150K ﹤0.01% 4023
2021
Q4
Sell
-27,293
Closed -$524K 3887
2021
Q3
$524K Buy
+27,293
New +$362K ﹤0.01% 2938

Other funds holding DVAX

Envestnet Asset Management's DVAX Position: Q1 2026 in Review

Envestnet Asset Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 12,796 shares — an estimated $197K sold.

Envestnet Asset Management first reported a position in DVAX in Q3 2021 and held it in 9 quarters. The position peaked at $524K in Q3 2021. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Envestnet Asset Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Envestnet Asset Management sold 12,796 Dynavax Technologies shares in Q1 2026, an estimated $197K.
  • Envestnet Asset Management first reported a position in Dynavax Technologies in Q3 2021 and held it in 9 quarters.
  • Envestnet Asset Management's Dynavax Technologies position peaked at $524K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.